Current controversies and challenges in allergic rhinitis management

David Price; Pete Smith; Peter Hellings; Nikos Papadopoulos; Wytske Fokkens; Antonella Muraro; Ruth Murray; Alison Chisholm; Pascal Demoly; Glenis Scadding; Joaquim Mullol; Phil Lieberman; Claus Bachert; Ralph Mösges; Dermot Ryan; Jean Bousquet

doi:https://doi.org/10.1586/1744666X.2015.1081814

Current controversies and challenges in allergic rhinitis management

David Price, Pete Smith, Peter Hellings, Nikos Papadopoulos, Wytske Fokkens, Antonella Muraro, Ruth Murray, Alison Chisholm, Pascal Demoly, Glenis Scadding, Joaquim Mullol, Phil Lieberman, Claus Bachert, Ralph Mösges, Dermot Ryan, Jean Bousquet

Research output: Contribution to journal › Review article › Academic › peer-review

31 Citations (Scopus)

Abstract

There are many obstacles in the path of effective allergy management, in general, and allergic rhinitis (AR) control, in particular. Chief among them are: insufficient symptom relief in some patients provided by some currently considered first-line AR treatments in real life; an over-reliance on randomized controlled trials to direct AR guideline recommendations; the need for a broader interpretation of the AR evidence base (to include randomized controlled trials and real-life studies); poorly designed and interpreted studies; and lack of an AR control concept and common language of control. These controversies are fully reviewed here and challenging solutions have been presented

Original language	English
Pages (from-to)	1205-1217
Journal	Expert Review of Clinical Immunology
Volume	11
Issue number	11
DOIs	https://doi.org/10.1586/1744666X.2015.1081814
Publication status	Published - 2015

Access to Document

https://doi.org/10.1586/1744666X.2015.1081814

Cite this

Price, D., Smith, P., Hellings, P., Papadopoulos, N., Fokkens, W., Muraro, A., Murray, R., Chisholm, A., Demoly, P., Scadding, G., Mullol, J., Lieberman, P., Bachert, C., Mösges, R., Ryan, D., & Bousquet, J. (2015). Current controversies and challenges in allergic rhinitis management. Expert Review of Clinical Immunology, 11(11), 1205-1217. https://doi.org/10.1586/1744666X.2015.1081814

@article{64052856792c4ab2b0a93e1560739747,

title = "Current controversies and challenges in allergic rhinitis management",

abstract = "There are many obstacles in the path of effective allergy management, in general, and allergic rhinitis (AR) control, in particular. Chief among them are: insufficient symptom relief in some patients provided by some currently considered first-line AR treatments in real life; an over-reliance on randomized controlled trials to direct AR guideline recommendations; the need for a broader interpretation of the AR evidence base (to include randomized controlled trials and real-life studies); poorly designed and interpreted studies; and lack of an AR control concept and common language of control. These controversies are fully reviewed here and challenging solutions have been presented",

author = "David Price and Pete Smith and Peter Hellings and Nikos Papadopoulos and Wytske Fokkens and Antonella Muraro and Ruth Murray and Alison Chisholm and Pascal Demoly and Glenis Scadding and Joaquim Mullol and Phil Lieberman and Claus Bachert and Ralph M{\"o}sges and Dermot Ryan and Jean Bousquet",

year = "2015",

doi = "https://doi.org/10.1586/1744666X.2015.1081814",

language = "English",

volume = "11",

pages = "1205--1217",

journal = "Expert Review of Clinical Immunology",

issn = "1744-666X",

publisher = "Expert Reviews Ltd.",

number = "11",

}

Price, D, Smith, P, Hellings, P, Papadopoulos, N, Fokkens, W, Muraro, A, Murray, R, Chisholm, A, Demoly, P, Scadding, G, Mullol, J, Lieberman, P, Bachert, C, Mösges, R, Ryan, D & Bousquet, J 2015, 'Current controversies and challenges in allergic rhinitis management', Expert Review of Clinical Immunology, vol. 11, no. 11, pp. 1205-1217. https://doi.org/10.1586/1744666X.2015.1081814

TY - JOUR

T1 - Current controversies and challenges in allergic rhinitis management

AU - Price, David

AU - Smith, Pete

AU - Hellings, Peter

AU - Papadopoulos, Nikos

AU - Fokkens, Wytske

AU - Muraro, Antonella

AU - Murray, Ruth

AU - Chisholm, Alison

AU - Demoly, Pascal

AU - Scadding, Glenis

AU - Mullol, Joaquim

AU - Lieberman, Phil

AU - Bachert, Claus

AU - Mösges, Ralph

AU - Ryan, Dermot

AU - Bousquet, Jean

PY - 2015

Y1 - 2015

N2 - There are many obstacles in the path of effective allergy management, in general, and allergic rhinitis (AR) control, in particular. Chief among them are: insufficient symptom relief in some patients provided by some currently considered first-line AR treatments in real life; an over-reliance on randomized controlled trials to direct AR guideline recommendations; the need for a broader interpretation of the AR evidence base (to include randomized controlled trials and real-life studies); poorly designed and interpreted studies; and lack of an AR control concept and common language of control. These controversies are fully reviewed here and challenging solutions have been presented

AB - There are many obstacles in the path of effective allergy management, in general, and allergic rhinitis (AR) control, in particular. Chief among them are: insufficient symptom relief in some patients provided by some currently considered first-line AR treatments in real life; an over-reliance on randomized controlled trials to direct AR guideline recommendations; the need for a broader interpretation of the AR evidence base (to include randomized controlled trials and real-life studies); poorly designed and interpreted studies; and lack of an AR control concept and common language of control. These controversies are fully reviewed here and challenging solutions have been presented

U2 - https://doi.org/10.1586/1744666X.2015.1081814

DO - https://doi.org/10.1586/1744666X.2015.1081814

M3 - Review article

C2 - 26325631

SN - 1744-666X

VL - 11

SP - 1205

EP - 1217

JO - Expert Review of Clinical Immunology

JF - Expert Review of Clinical Immunology

IS - 11

ER -